Electrical Stimulation for Erector Spinae Plane Catheter Insertion
Launched by STANFORD UNIVERSITY · Dec 8, 2022
Trial Information
Current as of January 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • elective total or total reverse shoulder arthroplasty
- Exclusion Criteria:
- • inability to provide consent
- • history of active opioid use
- • emergency procedures
- • shoulder arthroscopy
- • partial shoulder replacement
- • shoulder resurfacing
- • any revision shoulder surgery
- • any indwelling deep brain stimulator, pacemaker, and/or other neurostimulators
Trial Officials
Richard K Kim, MD
Principal Investigator
Stanford University
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials